All Kinds Of Alternatives Present Themselves With Anthera Pharmaceuticals Inc(ANTH), BioCryst Pharmaceuticals Inc(BIOC) and Genworth Financial Inc(GNW)

Posted by admin March 10, 2015 0 Comment 610 views

New York, NY – GDP INSIDER  –  03/10/2015.

This article discusses three companies: Anthera Pharmaceuticals Inc(NASDAQ:ANTH), BioCryst Pharmaceuticals Inc(NASDAQ:BIOC) and Genworth Financial Inc(NYSE:GNW).

Anthera Pharmaceuticals Inc(NASDAQ:ANTH) suffered a setback yesterday with the stock closing down 14.87% or $0.91 at $5.21 on active trading volume of 3.735 million shares, compared to its three month average trading volume of 1.131 million shares. Anthera Pharmaceuticals Inc has been flying high recently, with the stock rising from $2.51 on February 9th to a 52 week high of $6.37 on Friday. Yesterday’s drop brought the RSI down from close to 90 to 63.89 and with a one year target estimate of 6.75, this is a good time to hold.

Can Anthera Pharmaceuticals Inc Keep Pushing The Envelope? Click Here For Free ANTH Analysis.

BioCryst Pharmaceuticals Inc(NASDAQ:BIOC) the oncology laboratory service company focused on circulating tumor cells closed up 8.71% or $0.27 yesterday at $3.37 on slightly higher than average trading of 3.648 million shares. This was due to BioCryst Pharmaceuticals Inc releasing positive fourth quarter and full year results, which showed slightly higher revenues and lower costs, as well as a positive review of 2014 research progress. With several new validation tests for breast, lung, colon and other cancers in the works and a one year target estimate of $13.50, the stock has plenty of upside potential.

Should You Invest In BioCryst Pharmaceuticals Inc? Click Here For Free BIOS Analysis And See If BioCryst Pharmaceuticals Inc Can Cash In On Its Research.  

Genworth Financial Inc(NYSE:GNW) closed down 3% or $0.23 yesterday on light trading of 5.236 million shares compared to its three month average trading volume of 7.360 million. The stock has been in decline for the last year and has been underperforming the S&P 500 since June. The wealth management, investment and insurance company is down 56.21% over the last 52 weeks compared to the S&P 500 index which is up 10.72% for the same period. With EPS of -$2.51 and quarterly revenue growth of 0.5%, the best option is to sell.

See If Genworth Financial Inc Can Find A Way To Turn Around With Free GNW Analysis.

About UltimateStockAlerts provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word ULTIMATE to 555888 from your cell phone.

UltimateStockAlerts continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.

Disclosure:  UltimateStockAlerts is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit website, for complete risks and disclosures.

Write Your Comment